😊 About me
I am a Biomedical Informatics PhD student in the College of Medicine at The Ohio State University. My research focuses on precision oncology across renal cell carcinoma, brain metastases, and pan-cancer settings, with an emphasis on biomarker discovery, drug discovery, treatment response prediction, survival modeling, patient stratification, and tumor microenvironment characterization. With a computational background, I develop machine learning and deep learning approaches that integrate multi-omics and large-scale cancer data to support translational cancer research.
I am very fortunate to be advised by Dr. Elshad Hasanov in the Hasanov Lab at The Ohio State University Comprehensive Cancer Center - The James.
🔥 News
- [2026.06] Our ASCO 2026 RCC transcriptomic signatures work was featured by OncoDaily.
- [2026.05] Our explainable ML/AI survival modeling study was published in Neuro-Oncology Advances.
- [2026.05] Our renal cell carcinoma brain metastasis genomics preprint was released on bioRxiv.
- [2026.05] Our machine learning-based transcriptomic signatures study was selected for poster presentation at the ASCO 2026 Annual Meeting.
- [2026.05] Abstract 4526 was published in the Journal of Clinical Oncology ASCO 2026 Annual Meeting supplement.
- [2024.08] Started PhD training in Biomedical Informatics at The Ohio State University.
- [2024.08] Joined The Ohio State University Comprehensive Cancer Center as a Graduate Research Associate.
🌟 Highlights
2026 · Article · Neuro-Oncology Advances
Explainable ML/AI model for postoperative survival in RCC brain metastasis
This study develops an explainable machine learning framework for estimating postoperative survival in patients with renal cell carcinoma brain metastases. The work focuses on interpretable survival modeling in a clinically challenging metastatic setting.
2026 · Poster · JCO / ASCO Annual Meeting
Transcriptomic signatures for treatment outcome prediction in renal cell carcinoma
This work explores machine learning-based transcriptomic signatures to predict outcomes across targeted and immunotherapy regimens in renal cell carcinoma. It was selected for poster presentation at the ASCO 2026 Annual Meeting and later featured by OncoDaily.
ASCO Abstract · JCO DOI · Poster PDF · Video · OncoDaily
🧑⚖️ Academic Service
Peer reviewer for Journal of King Saud University - Computer and Information Sciences, Data Mining and Knowledge Discovery, Scientific Reports, and BMC Bioinformatics.

